Unknown

Dataset Information

0

Modulating native GABAA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death.


ABSTRACT: PURPOSE:Pediatric brain cancer medulloblastoma (MB) standard-of-care results in numerous comorbidities. MB is comprised of distinct molecular subgroups. Group 3 molecular subgroup patients have the highest relapse rates and after standard-of-care have a 20% survival. Group 3 tumors have high expression of GABRA5, which codes for the ?5 subunit of the ?-aminobutyric acid type A receptor (GABAAR). We are advancing a therapeutic approach for group 3 based on GABAAR modulation using benzodiazepine-derivatives. METHODS:We performed analysis of GABR and MYC expression in MB tumors and used molecular, cell biological, and whole-cell electrophysiology approaches to establish presence of a functional 'druggable' GABAAR in group 3 cells. RESULTS:Analysis of expression of 763 MB tumors reveals that group 3 tumors share high subgroup-specific and correlative expression of GABR genes, which code for GABAAR subunits ?5, ?3 and ?2 and 3. There are ~?1000 functional ?5-GABAARs per group 3 patient-derived cell that mediate a basal chloride-anion efflux of 2?×?109 ions/s. Benzodiazepines, designed to prefer ?5-GABAAR, impair group 3 cell viability by enhancing chloride-anion efflux with subtle changes in their structure having significant impact on potency. A potent, non-toxic benzodiazepine ('KRM-II-08') binds to the ?5-GABAAR (0.8 µM EC50) enhancing a chloride-anion efflux that induces mitochondrial membrane depolarization and in response, TP53 upregulation and p53, constitutively phosphorylated at S392, cytoplasmic localization. This correlates with pro-apoptotic Bcl-2-associated death promoter protein localization. CONCLUSION:GABRA5 expression can serve as a diagnostic biomarker for group 3 tumors, while ?5-GABAAR is a therapeutic target for benzodiazepine binding, enhancing an ion imbalance that induces apoptosis.

SUBMITTER: Kallay L 

PROVIDER: S-EPMC6478651 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Purpose</h4>Pediatric brain cancer medulloblastoma (MB) standard-of-care results in numerous comorbidities. MB is comprised of distinct molecular subgroups. Group 3 molecular subgroup patients have the highest relapse rates and after standard-of-care have a 20% survival. Group 3 tumors have high expression of GABRA5, which codes for the α5 subunit of the γ-aminobutyric acid type A receptor (GABA<sub>A</sub>R). We are advancing a therapeutic approach for group 3 based on GABA<sub>A</sub>R mod  ...[more]

Similar Datasets

| S-EPMC4873749 | biostudies-literature
| S-EPMC7139822 | biostudies-literature
| S-EPMC3974267 | biostudies-literature
| S-EPMC3764863 | biostudies-other
| S-EPMC4076519 | biostudies-literature
| S-EPMC2911342 | biostudies-literature
| S-EPMC3058165 | biostudies-literature
| S-EPMC7649024 | biostudies-literature
| S-EPMC3640040 | biostudies-literature
| S-EPMC3020259 | biostudies-literature